Global Drug Eluting Stent Market Size, Share, Growth, Trends, Company Analysis and Forecast 2020 to 2027

The global drug eluting stent market was valued at USD 5.89 Billion in 2019 and is expected to reach USD 9.10 Billion by year 2026, with a CAGR of 5.75 % during forecast period 2020 to 2027.

The study covers in-depth analysis of drug eluting stents and its extensive use in the cardiovascular diseases. Drug eluting stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Drug eluting stents are usually preferred over bare metal stents for most people. Drug eluting stents are generally to keep the blockage from recurring compared to bare metal stents. One of the major objectives of drug eluting stents is to limit neointimal hyperplasia. The global drug eluting stent market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for minimally invasive endovascular surgeries.

Key growth indicators of the drug-eluting stents market, including historical value and volume analysis, pricing analysis, value and supply chain analysis, and Y-o-Y growth trend analysis have been elucidated in the report. Readers can avail unbiased analysis and in-depth information on the drug-eluting stents market that can help them estimate both, qualitative and quantitative growth prospects of the market for the given timeframe.

VRR covers a detailed taxonomy of the drug-eluting stents market, along with an incisive outlook on the competitive scenario. The report profiles a list of companies operating in the drug-eluting stents market, wherein, the product portfolios, technological innovations, geographical expansion, and key growth strategies of these players have been mentioned in detail.

The report on the drug-eluting stents market allows stakeholders to understand key demand trends that end users may seek in the long run, and the appropriate sourcing strategy for the same. For companies involved in the drug-eluting stents market, the report helps understand key end users contributing to demand, allowing them to strategically formulate steps to enhance their sales prospects.

Key players in the global drug eluting market include Terumo Corporation, Biosensors, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation

Key Segments

  • In terms of product, the polymer-based segment dominated the global drug-eluting stents market in 2019. The segment is expected to maintain its dominance during the forecast period. Expansion of the segment is attributed to the availability of a wide range of polymer-based drug-eluting stents in the market, and their high rate of adoption for coronary interventions across the globe. Furthermore, recent product approvals are likely to boost the segment during the forecast period. In February 2019, Medtronic launched Resolute Onyx 2.0 mm DES in the U.S. This product enabled cardiologists to treat patients with coronary artery disease, and have small vessels that cannot be treated with larger size stent technologies available in the drug-eluting stents market.
  • In terms of drug, the sirolimus segment is estimated to expand at a high CAGR during the forecast period. Sirolimus is an extensively used drug for stents. Sirolimus coated drug-eluting stents have less late lumen loss and less angiographic restenosis.
  • In terms of generation, the global drug-eluting stents market has been classified into 1st generation, 2nd generation, 3rd generation, and 4th generation. The 3rd generation drug eluting stents segment is anticipated to hold a notable share of the global drug-eluting stents market by 2027. The 4th generation DES segment is projected to expand at a high CAGR during the forecast period.
  • Based on scaffold, the cobalt-chromium segment is anticipated to dominate the global drug-eluting stents market from 2019 to 2027, which is attributed to an increase in the use of cobalt-chromium stents and several market players manufacturing cobalt-chromium-based stents. Flexibility, long shelf-life, and better biocompatibility of cobalt-chromium-based drug-eluting stents are anticipated to attribute to its leading share of the global market.
  • Based on application, the global drug-eluting stents market has been bifurcated into coronary diseases and peripheral vascular diseases. The peripheral vascular diseases segment is likely to gain significant share and offer lucrative opportunities during the forecast period. This is attributed to an increase in the demand for drug-eluting vascular stents for the treatment of peripheral vascular diseases. As per the Cochrane Database Syst Rev 2016, in Western countries, the prevalence of peripheral vascular diseases is increasing among people above 50 years of age.
  • In terms of end user, the global drug-eluting stents market has been bifurcated into hospitals and ambulatory surgical centers. The ambulatory surgical centers segment is projected to expand at a notable CAGR due to a shift of coronary interventions from hospitals to ambulatory surgical centers.
  • The drug-eluting stents market size and forecast for each of these segments has been provided for the duration of 2016 to 2027. The CAGR of respective segments has also provided for the forecast period from 2020 to 2027, with 2020 as the base year.

Segmentation:

Drug-eluting stents Market by Product

  • Polymer-based
    • Biodegradable Polymers
    • Durable Polymers
  • Polymer-free

Drug-eluting stents Market by Drug

  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Others

Drug-eluting stents Market by Generation

  • 1st Generation
  • 2nd Generation
  • 3rd Generation
  • 4th Generation

Drug-eluting stents Market by Scaffold

  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Biodegradable
  • Others

Drug-eluting stents Market by Application

  • Coronary Diseases
  • Peripheral Vascular Diseases

Drug-eluting stents Market by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Research Methodology

The drug-eluting stents market report is a result of unique research methodology, which includes a perfect combination of primary research, secondary research, and expert panel reviews. The data repository for the drug-eluting stents market is updated on a continuous basis, with key stakeholders and their developments tracked at regular intervals.

Secondary sources such as annual reports, company websites, industry white papers, government publications, investor presentations, statistical databases, internal and external proprietary databases, and regulatory databases are generally referred to for developing preliminary market understanding.

Primary research involves interviews and e-mail interactions with C-level executives, KOLs, and regional officers of companies operating in the drug eluting stents market, for unbiased, yet detailed reviews on the drug-eluting stents market across different geographical divisions.

Information obtained from secondary resources and verified by primary resources have contributed to the compilation of the drug-eluting stents market report.

Section 1. Synopsis
1.1. Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Section 2. Executive Summary
2.1. Summary Snapshot, 2018 – 2026
Section 3. Indicative Metrics
3.1. Rising prevalence of cardiovascular diseases
3.2. Growing acceptance for minimally invasive endovascular surgeries
3.3. Rise in the geriatric population
Section 4. Drug Eluting Stents Segmentation & Impact Analysis
4.1. Drug Eluting Stents Segmentation Analysis
4.2. Drug Eluting Stents Market Value Chain Analysis, 2016-2026
4.3. Regulatory framework
4.4. Drug Eluting Stents Market Impact Analysis
4.4.1. Market driver analysis
4.4.1.1. Rise in public health awareness
4.4.1.2. Supportive regulatory environment for drug eluting products
4.4.2. Market restraint analysis
4.4.2.1. Strict regulatory approval process
4.4.2.2. Lack of skilled professionals
4.5. Key opportunities prioritized
4.6. Drug Eluting Stents Pricing Analysis
4.7. Industry analysis - Porter's
4.8. Drug Eluting Stents PESTEL Analysis
Section 5. Drug Eluting Stents Market By Coating Type Insights & Trends
5.1. Drug Eluting Stents Type dynamics & Market Share, 2018 & 2026
5.2. Polymer based coating
5.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
5.3. Polymer free coating
5.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
5.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 6. Drug Eluting Stents Market By Application Type Insights & Trends
6.1. Drug Eluting Stents Disease Type dynamics & Market Share, 2018 & 2026
6.2. Coronary Artery Disease
6.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
6.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
6.2.3. Peripheral Artery Disease
6.2.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
6.2.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 7. Drug Eluting Stents Market By End Use Insights & Trends
7.1. Drug Eluting Stents End Use dynamics & Market Share, 2018 & 2026
7.2. Hospital
7.2.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.2.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
7.3. Cardiology Centers
7.3.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.3.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
7.4. Ambulatory Surgical Centers
7.4.1. Market estimates and forecast, 2016 – 2026 (USD Million)
7.4.2. Market estimates and forecast, by region, 2016 – 2026 (USD Million)
Section 8. Drug Eluting Stents Market Regional Outlook
8.1. Drug Eluting Stents Market share by region, 2018 & 2026
8.2. North America
8.2.1. North America Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.2. North America Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.3. North America Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.4. North America Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.2.5. U.S.
8.2.5.1. U.S. Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.5.2. U.S. Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.5.3. U.S. Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.5.4. U.S. Drug Eluting Stents Market estimates and forecast by End use, 2016 – 2026, (USD Million)
8.2.6. Canada
8.2.6.1. Canada Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.2.6.2. Canada Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.2.6.3. Canada Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.2.6.4. Canada Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3. Europe
8.3.1. Europe Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.2. Europe Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.3. Europe Drug Eluting Stents Market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.4. Europe Drug Eluting Stents Market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.5. Germany
8.3.5.1. Germany Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.5.2. Germany Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.5.3. Germany Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.5.4. Germany Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.6. France
8.3.6.1. France Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.6.2. France Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.6.3. France Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.6.4. France Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.7. U.K.
8.3.7.1. U.K Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.7.2. U.K Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.7.3. U.K. Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.7.4. U.K. Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.8. Spain
8.3.8.1. Spain Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.8.2. Spain Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.8.3. Spain. Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.8.4. Spain Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.9. Italy
8.3.9.1. Italy Drug Eluting Stents Market estimates and forecast, 2016 – 2026, (USD Million)
8.3.9.2. Italy Drug Eluting Stents Market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.9.3. Italy Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.9.4. Italy Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.3.10. Rest of Europe
8.3.10.1. Rest of Europe Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.3.10.2. Rest of Europe Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.3.10.3. Rest of Europe Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.3.10.4. Rest of Europe Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.2. Asia Pacific Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.3. Asia Pacific Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.4. Asia Pacific Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.5. China
8.4.5.1. China Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.5.2. China Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.5.3. China Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.5.4. China Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.6. Japan
8.4.6.1. Japan Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.6.2. Japan Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.6.3. Japan Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.6.4. Japan Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.7. India
8.4.7.1. India Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.7.2. India Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.7.3. India Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.7.4. India Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.4.8. Rest of Asia Pacific
8.4.8.1. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.4.8.2. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.4.8.3. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.4.8.4. Rest of Asia Pacific Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.5. Middle East & Africa
8.5.1. Middle East and Africa Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.5.2. Middle East and Africa Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.5.3. Middle East and Africa Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.5.4. Middle East and Africa Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.6. Latin America
8.6.1. Latin America Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.6.2. Latin America Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.6.3. Latin America Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.6.4. Latin America Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
8.6.5. Brazil
8.6.5.1. Brazil Drug Eluting Stents market estimates and forecast, 2016 – 2026, (USD Million)
8.6.5.2. Brazil Drug Eluting Stents market estimates and forecast by Coating, 2016 – 2026, (USD Million)
8.6.5.3. Brazil Drug Eluting Stents market estimates and forecast By Application Type, 2016 – 2026, (USD Million)
8.6.5.4. Brazil Drug Eluting Stents market estimates and forecast by End Use, 2016 – 2026, (USD Million)
Section 9. Competitive Landscape
9.1. Market Revenue Share by Manufacturers
9.2. Manufacturing Cost Breakdown Analysis
9.3. Mergers & Acquisitions
9.4. Strategy Benchmarking
9.5. Vendor Landscape
Section 10. Company Profiles
10.1. Terumo Corporation
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Length Benchmarking
10.1.4. Strategic Initiatives
10.2. Biosensors
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Length Benchmarking
10.2.4. Strategic Initiatives
10.3. Abbott Laboratories
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Length Benchmarking
10.3.4. Strategic Initiatives
10.4. Boston Scientific Corporation
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Length Benchmarking
10.4.4. Strategic Initiatives
10.5. Medtronic PLC
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Length Benchmarking
10.5.4. Strategic Initiatives
10.6. Biotronik SE & Co. KG
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Length Benchmarking
10.6.4. Strategic Initiatives
10.7. MicroPort Scientific Corporation
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Length Benchmarking
10.7.4. Strategic Initiatives
10.7.5. Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert